🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,760 results for “Pharm” Clear

  1. VX-668

    Vertex Pharmaceuticals (Australia) Pty.

    Alpha-1 Antitrypsin Deficiency

    phase 1 small molecule completed

    1 trial

  2. VX-708

    Vertex Pharmaceuticals (Australia) Pty.

    Acute Pain

    phase 1 small molecule completed

    1 trial

  3. VX-708

    Vertex Pharmaceuticals (Australia) Pty.

    Pain

    phase 1 small molecule completed

    1 trial

  4. VX-770

    Vertex Pharmaceuticals (Australia) Pty.

    In Development for Cystic Fibrosis

    phase 1 small molecule completed

    2 trials

  5. VX-828

    Vertex Pharmaceuticals (Australia) Pty.

    Cystic Fibrosis

    phase 1 small molecule active

    2 trials

  6. VX-840

    Vertex Pharmaceuticals (Australia) Pty.

    APOL1-mediated Kidney Disease

    phase 1 small molecule completed

    1 trial

  7. VX-973

    Vertex Pharmaceuticals (Australia) Pty.

    Pain

    phase 1 small molecule completed

    2 trials

  8. VX-985 or matching placebo

    Vertex Pharmaceuticals (Australia) Pty.

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial

  9. VX-993

    Vertex Pharmaceuticals (Australia) Pty.

    Pain

    phase 1 small molecule completed

    6 trials

  10. Vagal Nerve Stimulation

    Rhythm Pharmaceuticals Netherlands B.V.

    Inflammation

    phase 1 other completed

    1 trial

  11. Vagus Nerve Stimulation

    Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

    Refractory Epilepsy

    phase 1 other active

    1 trial

  12. Valacyclovir

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  13. Vantictumab

    Mereo BioPharma Group plc

    Pancreatic Cancer

    phase 1 small molecule completed

    1 trial

  14. Vantictumab combined with paclitaxel

    Mereo BioPharma Group plc

    Metastatic Breast Cancer

    phase 1 small molecule completed

    1 trial

  15. Vanzacaftor

    Vertex Pharmaceuticals (Australia) Pty.

    Cystic Fibrosis

    phase 1 small molecule completed

    1 trial

  16. Vehicle to Methylprednisolone Aceponate Ointment, Methylprednisolone Aceponate Ointment, Advantan® 0,1% Salbe

    Alphapharm Pty Ltd

    Mild to moderate atopic dermatitis

    phase 1 small molecule active

    1 trial

  17. Velusetrag

    Theravance Biopharma Ireland Umited

    Alzheimer's Disease

    phase 1 small molecule completed

    1 trial

  18. Venetoclax

    Karyopharm Therapeutics Inc

    Diffuse Large B-cell Lymphoma

    phase 1 small molecule completed

    1 trial

  19. Venetoclax

    Karyopharm Therapeutics Inc

    Acute Leukemia of Ambiguous Lineage in Relapse

    phase 1 small molecule active

    1 trial

  20. Venlafaxine 25 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  21. Venlafaxine Hydrochloride

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    3 trials

  22. Verdinexor

    Karyopharm Therapeutics Inc

    Healthy

    phase 1 small molecule terminated

    1 trial

  23. Virus-specific T-cell Immunity for the Treatment of Some Resistant Viral Infections After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

    Istituto Gentili S.r.l.

    Patients who have received an allogeneic haematopoietic stem cell transplant and who have developed post-transplant viral reactivation (CMV, Adenovirus, EBV) resistant to pharmacological therapies.

    phase 1 other active

    1 trial

  24. Voclosporin

    Aurinia Pharmaceuticals

    Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources